Clinical Trials › NCT04387734
Active, Not RecruitingPhase 4
Effects of Ocrevus in Relapsing Multiple Sclerosis
Sponsored by Georgia State University
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 60
Target enrollment
1
U.S. states
Feb 2021
Start date
Apr 2026
Expected completion
Interventions / Treatments
OcrelizumabPlatform
Conditions studied
Relapsing Multiple Sclerosis
Where this trial is running (2 sites)
Georgia2 sites
Atlanta · Atlanta
MS centers in Georgia
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View Georgia centersMore Phase 4 trials
Browse all Phase 4 MS trialsCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
